<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="InfertilityAgents" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">livertox</book-id>
    <book-title-group>
      <book-title>LiverTox</book-title>
      <subtitle>Clinical and Research Information on Drug-Induced Liver Injury</subtitle>
    </book-title-group>
    <pub-date date-type="pubr" publication-format="electronic">
      <year>2012</year>
    </pub-date>
    <publisher>
      <publisher-name>National Institute of Diabetes and Digestive and Kidney Diseases</publisher-name>
      <publisher-loc>Bethesda (MD)</publisher-loc>
    </publisher>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">InfertilityAgents</book-part-id>
      <title-group>
        <title>Infertility Agents</title>
      </title-group>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>7</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="livertox">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury</related-object>
      <related-object link-type="previous-part-link" source-id="livertox" document-id="Indomethacin" document-type="chapter">Indomethacin</related-object>
      <related-object link-type="next-part-link" source-id="livertox" document-id="Infliximab" document-type="chapter">Infliximab</related-object>
    </book-part-meta>
    <body>
      <sec id="InfertilityAgents.OVERVIEW">
        <title>OVERVIEW</title>
        <p content-type="pubmed-excerpt">Infertility affects at least 10% of couples and the rate may be increasing as women in developed countries delay childbearing until later in life. The source of the infertility is primarily the woman in one-third, the man in one-third, and both in one-third of couples. Management and treatment of infertility usually begins with diagnosis of the cause. In some instances, infertility is not correctable, but in many, fertility can be corrected or improved in part by hormonal or antihormonal therapies and assisted reproductive techniques.</p>
        <p content-type="pubmed-excerpt">Anovulation in women is perhaps the single most common cause of infertility in women and can be modulated by pharmaceutical approaches. Induction of ovulation can be stimulated by antiestrogens (clomiphene, tamoxifen) or by administration or stimulation of follicle stimulating hormone (FSH) with or without luteinizing hormone (LH) and human chorionic gonadotropin (hCG). Drugs for infertility are very rare causes of drug induced liver injury, but may be associated with liver abnormalities as a part of the ovarian hyperstimulation syndrome (OHSS). The following agents are discussed in LiverTox:</p>
        <list list-type="bullet">
          <list-item>
            <p>Antiestrogens</p>
            <list list-type="bullet">
              <list-item>
                <p>
                  <related-object source-id="livertox" document-id="Clomiphene">Clomiphene</related-object>
                </p>
              </list-item>
              <list-item>
                <p>
                  <related-object source-id="livertox" document-id="Letrozole">Letrozole</related-object>
                </p>
              </list-item>
              <list-item>
                <p>
                  <related-object source-id="livertox" document-id="Tamoxifen">Tamoxifen</related-object>
                </p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p><related-object source-id="livertox" document-id="Gonadotropins">Gonadotropins</related-object>
<list list-type="bullet"><list-item><p><related-object source-id="livertox" document-id="Gonadotropins">Human Chorionic Gonadotropin (hCG)</related-object></p></list-item><list-item><p><related-object source-id="livertox" document-id="Gonadotropins">Follicle Stimulating Hormone (FSH)</related-object></p></list-item><list-item><p><related-object source-id="livertox" document-id="Gonadotropins">Luteinizing Hormone (LH)</related-object></p></list-item><list-item><p><related-object source-id="livertox" document-id="Gonadotropins">Gonadotropin Releasing Hormone (GnRH)</related-object></p></list-item></list></p>
          </list-item>
        </list>
      </sec>
      <sec id="InfertilityAgents.ANNOTATED_BIBLIOGRAPHY">
        <title>ANNOTATED BIBLIOGRAPHY</title>
        <p content-type="pubmed-excerpt">References updated: 19 July 2017</p>
        <ref-list id="InfertilityAgents.ANNOTATED_BIBLIOGRAPHY.reflist0">
          <ref id="InfertilityAgents.R1">
            <mixed-citation publication-type="other">Zimmerman HJ. Hormonal derivatives and related drugs. In, Zimmerman, HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott, 1999: pp. 555-88.<annotation><p><italic toggle="yes">(Textbook of hepatotoxicity published in 1999 mentions that clomiphene has been linked unconvincingly to one case of hepatoblastoma [in a child born to a woman who received clomiphene] and one adenoma; gonadotropins and fertility agents are not discussed).</italic></p></annotation></mixed-citation>
          </ref>
          <ref id="InfertilityAgents.R2">
            <mixed-citation publication-type="other">Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013.<annotation><p><italic toggle="yes">(Textbook on hepatotoxicity; gonadotropins and fertility agents are not discussed).</italic></p></annotation></mixed-citation>
          </ref>
          <ref id="InfertilityAgents.R3">
            <mixed-citation publication-type="other">Schimmer BP, Parker KL. Contraception and pharmacotherapy of obstetrical and gynecological disorders. In, Brunton LL, Chabner BA, Knollman BC, eds. Goodman &#x00026; Gilman's the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill, 2011, pp. 1833-52.<annotation><p><italic toggle="yes">(Textbook of pharmacology and therapeutics).</italic></p></annotation></mixed-citation>
          </ref>
          <ref id="InfertilityAgents.R4">
            <mixed-citation publication-type="other">Levin ER, Hammes SR. Estrogens and progestins. In, Brunton LL, Chabner BA, Knollman BC, eds. Goodman &#x00026; Gilman's the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill, 2011, pp. 1163-94.<annotation><p><italic toggle="yes">(Textbook of pharmacology and therapeutics).</italic></p></annotation></mixed-citation>
          </ref>
          <ref id="InfertilityAgents.R5">
            <mixed-citation publication-type="journal">Drugs for ovulation induction. Med Lett Drugs Ther 2011; 53 (1376): 86-8. <annotation><p><italic toggle="yes">(Concise review of the efficacy and safety of drugs used for ovarian induction mentions that common side effects of clomiphene are hot flushes, gastrointestinal upset, headache, breast discomfort and uterine bleeding. Side effects of FSH, LH and hCG include injection site reactions, headache, abdominal pain and nausea; in addition, clomiphene, FSH and LH have been linked to the ovarian hyperstimulation syndrome [OHSS] which can be severe and even fatal; no mention of ALT elevations or hepatotoxicity).</italic></p></annotation><pub-id pub-id-type="pmid">22033212</pub-id></mixed-citation>
          </ref>
        </ref-list>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
